PET PET
  • My Account
  • Subscribe
Become a Friend Donate
  • About Us
    • People
    • Press Office
    • Our History
  • Get Involved
    • Become a Friend of PET
    • Volunteer
    • Campaigns
    • Writing Scheme
    • Partnership and Sponsorship
    • Advertise with Us
  • Donate
    • Become a Friend of PET
  • BioNews
    • News
    • Comment
    • Reviews
    • Elsewhere
    • Topics
    • Glossary
    • Newsletters
  • Events
    • Upcoming Events
    • Previous Events
  • Engagement
    • Policy and Projects
      • Resources
    • Education
  • Jobs & Opportunities
  • Contact Us
  • About Us
    • People
    • Press Office
    • Our History
  • Get Involved
    • Become a Friend of PET
    • Volunteer
    • Campaigns
    • Writing Scheme
    • Partnership and Sponsorship
    • Advertise with Us
  • Donate
    • Become a Friend of PET
  • BioNews
    • News
    • Comment
    • Reviews
    • Elsewhere
    • Topics
    • Glossary
    • Newsletters
  • Events
    • Upcoming Events
    • Previous Events
  • Engagement
    • Policy and Projects
      • Resources
    • Education
  • Jobs & Opportunities
  • Contact Us
  • My Account
  • Subscribe
  • Privacy Statement
  • Advertising Policy
  • Thanks and Acknowledgements
PETBioNewsNewsHope for new prostate cancer test

BioNews

Hope for new prostate cancer test

Published 9 June 2009 posted in News and appears in BioNews 508

Author

Lorna Stewart

Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the output from a DNA sequencing machine.
CC BY 4.0
Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the sequencing output from an automated DNA sequencing machine.

Screening the genetic material present in patients' urine could distinguish between aggressive from dormant prostate cancers, suggests a study published this month in the British Journal of Cancer. The research paper reports pilot findings from 11 prostate cancer patients and may provide new hope for the 34,000...

Screening the genetic material present in patients' urine could distinguish between aggressive from dormant prostate cancers, suggests a study published this month in the British Journal of Cancer. The research paper reports pilot findings from 11 prostate cancer patients and may provide new hope for the 34,000 men who are diagnosed with the disease each year. Differentiating between aggressive and dormant forms of prostate cancer is important since treatment is invasive and can leave men with long-term side effects, including incontinence and impotence. Conversely, dormant forms can be left untreated as they often do not progress.


The main method for distinguishing aggressive tumours currently is based upon detecting levels of protein in the urine. However, this method leads to false positives (classifying aggressive cancer as present when it is not) because other prostate conditions can cause excretion of the same proteins.


The new approach, led by Dr Jonas Nilsson from Umea University, Sweden, takes a step further back along the process and looks at the RNA which produces these proteins in the first place. RNA is the molecule responsible for 'reading' the DNA code  that makes up a gene, enabling the cell to make whichever proteins have been copied into RNA. The team showed that aggressive and dormant cancers showed differing RNA patterns, reflecting different gene activity. The results from this pilot study suggest that genetic information inside fatty deposits excreted in urine can be used for tumour detection and discovery of biomarkers of prostate cancer.


Dr Lesley Walker, director of cancer information at Cancer Research UK, said, 'This technique is a fresh view on an old problem and could really help scientists find that elusive biomarker. It's still unclear what the best treatment approach is for early prostate cancer, so it's important we find answers to this as soon as possible. Distinguishing the aggressive tumours that must be treated from those that don't need treatment will go a long way towards resolving this issue'.

Related Articles

Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the output from a DNA sequencing machine.
CC BY 4.0
Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the sequencing output from an automated DNA sequencing machine.
News
21 November 2012 • 2 minutes read

Key genetic clue in fighting prostate cancer

by Sarah Pritchard

US researchers have made a discovery that might help doctors distinguish between benign and more aggressive forms of prostate cancer. The team reports that a difference in the genetic make-up of prostate tumours could indicate which are likely to metastasize and spread through the body, and which will be slow-growing and non-fatal...

Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the output from a DNA sequencing machine.
CC BY 4.0
Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the sequencing output from an automated DNA sequencing machine.
News
4 October 2012 • 2 minutes read

Prostate cancer genetic test could prevent surgery, say researchers

by Vicki Kay

A genetic screening test could help doctors to identify men with the most aggressive types of prostate cancer, UK scientists believe. The test could save men with milder forms of the disease from unnecessary surgery and its potentially serious side effects...

Image by K Hardy via the Wellcome Collection. Depicts a human embryo at the blastocyst stage (about six days after fertilisation) 'hatching' out of the zona pellucida.
CC BY 4.0
Image by K Hardy via the Wellcome Collection. Depicts a human embryo at the blastocyst stage (about six days after fertilisation) 'hatching' out of the zona pellucida.
News
3 December 2010 • 1 minute read

Scientists find key protein involved in prostate stem cell maintenance

by Julianna Photopoulos

A protein that regulates prostate stem cell self-renewal and maintenance has been identified by US researchers. The so-called Bmi-1 protein also plays a role in the transformation of healthy prostate cells into cancerous ones...

Leave a Reply Cancel reply

You must be logged in to post a comment.

« Genes identified that influence gambling patterns and anger management

Data-Label The UK's Leading Supplier Of Medical Labels & Asset Labels

RetiringDentist.co.uk The UK's Leading M&A Company.
easyfundraising
amazon

This month in BioNews

  • Popular
  • Recent
13 June 2022 • 2 minutes read

Drop in diversity of blood stem cells leads to old-age health issues

5 July 2022 • 1 minute read

No difference between fresh and frozen sperm for IUI

4 July 2022 • 2 minutes read

Shorter IVF protocol reduces risk of OHSS

4 July 2022 • 2 minutes read

USA scrambles to understand implications of Roe v Wade on fertility industry

4 July 2022 • 2 minutes read

Genetic and epigenetic causes of IVF embryo arrest discovered

4 July 2022 • 2 minutes read

Dutch donor-conceived people seek answers

Subscribe to BioNews and other PET updates for free.

Subscribe
  • Twitter
  • Facebook
  • Instagram
  • LinkedIn
  • YouTube
  • RSS
Wellcome
Website redevelopment supported by Wellcome.

Website by Impact Media Impact Media

  • Privacy Statement
  • Advertising Policy
  • Thanks and Acknowledgements

© 1992 - 2022 Progress Educational Trust. All rights reserved.

Limited company registered in England and Wales no 07405980 • Registered charity no 1139856

Subscribe to BioNews and other PET updates for free.

Subscribe
PET PET

PET is an independent charity that improves choices for people affected by infertility and genetic conditions.

  • Twitter
  • Facebook
  • Instagram
  • LinkedIn
  • YouTube
  • RSS
Wellcome
Website redevelopment supported by Wellcome.

Navigation

  • About Us
  • Get Involved
  • Donate
  • BioNews
  • Events
  • Engagement
  • Jobs & Opportunities
  • Contact Us

BioNews

  • News
  • Comment
  • Reviews
  • Elsewhere
  • Topics
  • Glossary
  • Newsletters

Other

  • My Account
  • Subscribe

Website by Impact Media Impact Media

  • Privacy Statement
  • Advertising Policy
  • Thanks and Acknowledgements

© 1992 - 2022 Progress Educational Trust. All rights reserved.

Limited company registered in England and Wales no 07405980 • Registered charity no 1139856